Dariusz Koziorowski
Overview
Explore the profile of Dariusz Koziorowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kasprzak J, Dulski J, Przytula F, Koziorowski D, Kwasniak-Butowska M, Soltan W, et al.
Neurol Neurochir Pol
. 2025 Feb;
59(1):62-69.
PMID: 40007330
Aim Of Study: To investigate the treatment strategies of Parkinson's Disease (PD) among movement disorder specialists in tertiary centres in Poland, and how literature warnings (levodopa and dopamine agonist phobia)...
2.
Cwiklinska A, Przewodowska D, Koziorowski D, Szlufik S
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766134
Gliomas are a wide group of common brain tumors, with the most aggressive type being glioblastoma multiforme (GBM), with a 5-year survival rate of less than 5% and a median...
3.
Roszkowska Z, Surma A, Koziorowski D, Krolicki L, Milanowski L
Neurol Neurochir Pol
. 2024 Dec;
58(6):627-628.
PMID: 39737590
No abstract available.
4.
Poplawska-Domaszewicz K, Siuda J, Rudzinska-Bar M, Budrewicz S, Koziorowski D, Bogucki A, et al.
Neurol Neurochir Pol
. 2024 Dec;
58(6):608-616.
PMID: 39737586
Introduction: In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available. Material And Methods: We aimed to produce a consensus recommendation from Polish movement...
5.
Gurevich T, Evans A, Hassin-Baer S, Kagi G, Koziorowski D, Roszmann A, et al.
Digit Health
. 2024 Sep;
10:20552076241271847.
PMID: 39224799
Background: Levodopa-carbidopa intestinal gel (LCIG) is a continuously delivered Parkinson's disease therapy intended to stabilize plasma levodopa levels. Patients receiving LCIG require education and follow-up. Some LCIG support programs use...
6.
Cwiklinska A, Procyk G, Koziorowski D, Szlufik S
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125813
Progressive supranuclear palsy (PSP) is a rare, neurodegenerative movement disorder. Together with multiple system atrophy (MSA), Dementia with Lewy bodies (DLB), and corticobasal degeneration (CBD), PSP forms a group of...
7.
Sadowski K, Zajac W, Milanowski L, Koziorowski D, Figura M
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062985
Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by numerous motor and non-motor symptoms. Recent data highlight a potential interplay between the gut microbiota and the pathophysiology of PD....
8.
Skwara J, Nowicki M, Sharif L, Milanowski L, Dulski J, Elert-Dobkowska E, et al.
J Neural Transm (Vienna)
. 2024 Jun;
131(9):1013-1024.
PMID: 38916623
Benign hereditary chorea (BHC) is an inherited neurological disorder consisting of childhood-onset, nonprogressive chorea, generally without any other manifestations. In most reported cases, the inheritance of BHC is autosomal dominant...
9.
Figura M, Mrozowicz A, Milanowski L, Szlufik S, Rackowska E, Lypkan H, et al.
J Parkinsons Dis
. 2024 Jun;
14(5):1039-1049.
PMID: 38905055
Background: Levodopa is the gold standard of treatment in Parkinson's disease (PD). Its clinical effect changes as the disease progresses. Wearing off is a frequent first manifestation of motor fluctuations....
10.
Nowak J, Antoniak A, Kopczynski M, Zajac W, Sadowski K, Milanowski L, et al.
Neurol Neurochir Pol
. 2024 Jun;
58(3):338-346.
PMID: 38845557
Aim Of Study: The Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) is a novel, disease-specific self-report questionnaire used to quantitatively assess features of gastrointestinal dysfunction symptoms in patients with Parkinson's...